<DOC>
	<DOCNO>NCT00410371</DOCNO>
	<brief_summary>This study intend compare pharmacokinetic characteristic , safety tolerability two formulation lamotrigine healthy male female volunteer</brief_summary>
	<brief_title>Study Compare Two Formulations Lamotrigine Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Body weight &gt; 50 kg ( male ) &gt; 45 kg ( female ) BMI within range 19 30 kg/m2 inclusive . Female subject childbearing potential eligible participate unwilling unable use appropriate method contraception least 30 day prior first study drug 30 day . Female subject pregnant ( positive serum human chorionic gonadotrophin ( hCG ) test Screening predose study ) lactating . Female subject use hormonal contraceptive precaution include progesteronecoated intrauterine device ( IUD ) . Female subject use hormonal replacement therapy . History regular alcohol consumption Current smokers 10 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>tolerability</keyword>
	<keyword>safety</keyword>
	<keyword>Pharmacokinetic characteristic</keyword>
</DOC>